文献速递慢性肾脏病水电解质与酸碱血液净化与透析

晚期CKD透析前钾变异性与透析后死亡率的关联

Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD.
PubMed 文献 · Kidney Int Rep · 2021-01-14

本研究纳入34,167名美国退伍军人晚期非透析依赖CKD患者,分析透析前3年血钾变异性与透析启动后6个月全因及心血管死亡率的关系。采用线性混合效应模型计算钾变异性,多变量Cox和Fine-Gray回归显示,较高钾变异性与全因死亡率风险升高独立相关(最高四分位vs最低:aHR 1.14,95%CI 1.03-1.25),但与心血管死亡率无显著关联。

要点

  • 透析前3年血钾变异性较高与透析后6个月全因死亡率增加14%相关。
  • 钾变异性与心血管死亡率无显著关联。
  • 临床应关注晚期CKD患者透析前血钾波动。

核心结论

  • 较高透析前血钾变异性与透析启动后全因死亡率升高独立相关。

研究设计与样本

  • 回顾性队列研究,纳入34,167名美国退伍军人晚期非透析依赖CKD患者,透析前3年期间每年至少一次血钾测量。

主要发现

  • 钾变异性最高四分位组与最低组相比,全因死亡调整风险比1.14(95%CI 1.03-1.25)。
  • 心血管死亡调整风险比0.99(95%CI 0.85-1.16),无显著关联。

临床怎么用

  • 对于晚期非透析依赖CKD患者,应关注透析前血钾波动,可能有助于识别透析后高死亡风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with advanced non-dialysis-dependent chronic kidney disease (NDD-CKD) are prone to potassium (K) imbalances due to reduced kidney function. Both hypo- and hyperkalemia are associated with increased mortality; however, it is unclear if K variability before dialysis initiation is associated with outcomes after dialysis initiation. METHODS: We identified 34,167 US veterans with advanced NDD-CKD transitioning to dialysis between October 1, 2007, through March 31, 2015, who had at least 1 K measurement each year over a 3-year period before transition (3-year prelude). For each patient, a linear mixed-effects model was used to regress K over time (in years) over the 3-year prelude to derive K variability (square root of the average squared distance between the observed and estimated K). The main outcomes of interest were 6-month all-cause and cardiovascular mortality after dialysis initiation. Multivariable Cox and Fine-Gray competing risk regression adjusted for 3-year prelude K intercept, K slope (per year), demographics, smoking status, comorbidities, length of hospitalizations, body mass index, vascular access type, medications, average estimated glomerular filtration rate, and number of K measurements over the 3-year prelude were used to assess the association of K variability (expressed as quartiles) with all-cause and cardiovascular mortality, respectively. RESULTS: Higher prelude K variability was associated with higher multivariable-adjusted risk of all-cause mortality but not cardiovascular mortality (adjusted hazard/subhazard ratios [95% confidence interval] for highest quartile [vs. lowest] of K variability, 1.14 [1.03-1.25] and 0.99 [0.85-1.16] for all-cause and cardiovascular mortality, respectively). CONCLUSION: Higher K variability is associated with higher all-cause mortality after dialysis initiation.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Dashputre AA, Potukuchi PK, Sumida K, et al. Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD. Kidney Int Rep. 2021. PMID: 33615062. doi:10.1016/j.ekir.2020.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。